Dispensing Pharmacy, In Office Dispensing, Worksite Clinic

Home Delivery Pharmacy Adds Value to Worksite Clinics

Onsite Dispensing

The traditional onsite clinic model integrates prepackaged medications for point-of -care dispensing.  This high value approach provides several key benefits:

  • Enhanced patient access to prescriptions increases compliance and reduces time off of work.
  • Onsite medications are a key driver of clinic utilization.
  • Prescription costs are lower due to wholesale access to medications.

Though the benefits are high, there are challenges with the onsite dispensing model:

  • Limited formularies capture a relatively small portion of overall prescribing, requiring patients to fill many prescriptions outside of the clinic.
  • Larger formularies increase clinical staff workload.

Home Delivery Pharmacy

Home delivery pharmacy provides a way for worksite clinics to extend the value of onsite/nearsite accessibility by delivering prescription medications directly to the patient’s home. Key benefits of this approach include:

  1. Broad access to virtually any medication.
  2. Option to redirect medication refills to the pharmacy rather than fill them in the clinic.
  3. Targeted cost containment programs for high cost drugs.
  4. Clinical coordination with pharmacists closely aligned with onsite clinic patients.
  5. Quick access to pharmacists for medication support.

A combined onsite and home delivery medication management model ensures that the worksite clinic is providing the best of both worlds to its patients and associated cost savings to the sponsoring employer. Successful programs can see prescription cost reductions of 20%-40% for medications offered through the onsite and home delivery dispensing model.

Call us at 800.722.0772 to learn how home delivery pharmacy can bring additional value to your worksite clinic.

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading